 |
 |
| - Medical Directors |
| - Radiation Oncologists |
| - Surgeons |
 |
 |
 |
 |
Our Physicians
Medical Director
Dr. Luther W. Brady
Luther W. Brady, M.D., one of the world’s foremost oncologists, was born in North Carolina and received his undergraduate degree and medical education at George Washington University in Washington, DC. He received post-graduate training in radiology and radiation oncology at the US Naval Hospital in Bethesda and in Philadelphia at Jefferson Medical College and the Hospital of the University of Pennsylvania. Except for a year at Harvard Medical School and a brief tenure in New York with the College of Physicians and Surgeons of Columbia University, his entire career has been in Philadelphia, first at the University of Pennsylvania, and since the fall of 110510, at Hahnemann University Hospital. He has held the rank of Professor since 11063 and, in 11070, was appointed Chairman of the Department of Radiation Oncology and Nuclear Medicine. In 11075, he was named the Hylda Cohn/American Cancer Society Professor of Clinical Oncology. Hahnemann recognized Dr. Brady’s enormous professional commitment and dedication by establishing the Luther W. Brady Pavilion in 1970.
When Hahnemann University and Medical College of Pennsylvania merged in 1994, he was named Head of the combined MCP/Hahnemann University Department of Radiation Oncology and Nuclear Medicine. Dr. Brady stepped down in 1996, having built during a distinguished tenure a department reputed for its teaching excellence and innovative approaches in the treatment of cancer. In June 1995, the University announced establishment of the Luther W. Brady, M.D. Professorship in Radiation Oncology in his honor. The following year, 1997, the Faculty Committee promoted Dr. Brady to the institution’s highest academic rank of University Professor. In 1999, in recognition of exceptional contribution and accomplishment in the field of oncology, the American Medical Association presented Dr. Brady with the AMA Distinguished Service Award Gold Medal. Later that same year the Philadelphia County Medical Society granted him the 1999 Strittmatter Award, one of the most illustrious honors given for high achievement in the field of medicine. The Chairmanship in the Department of Radiation Oncology became open unexpectedly in January 2001, and Tenet Health System appointed Dr. Brady Interim-Chair of Radiation Oncology at Hahnemann University, MCP and Graduate Hospitals until a suitable candidate is located.
No one in the specialty of radiation oncology had had the breadth and depth of involvement as Dr. Brady. During his career, he has served as President of every major professional society related to the field. He is a Fellow of the American College of Radiology and a Fellow of the American College of Radiation Oncology. He has been a member of the American College of Radiology Board of Chancellors, Chairman of the Commission on Radiation Oncology, and has served on numerous College committees. As well, he was Chairman of the Radiation Therapy Oncology Group, a nationwide consortium to evaluate forms of cancer treatment. From 1991 to 1993, he served as appointed Chairman of the Radiation Oncology Committee for ACGME (Accreditation Council for Graduate Medical Education).
One of the most prolific investigators in the history of radiation oncology, Dr. Brady’s publications have ranged from tumors of the eye and orbit, a subject on which he is considered a world authority, to the more common cancers of the breast, lung, cervix, malignant lymphoma and Hodgkin’s disease. He has over 600 publications to his credit. Dr. Brady has received countless honors, medals and awards throughout his distinguished career.
Associate Medical Director
Dr. John Lamond
John Lamond, M.D., graduated from Hahnemann Medical School with AOA honors in 1991 after being awarded a full merit scholarship. During his Radiation Oncology residency at the University of Wisconsin, he was trained in radiosurgery and authored many articles on the subject. He was awarded numerous grants to perform research on radiation sensitizers, and won an American Cancer Society award in 1995. He’s authored articles on the radiosensitizing properties of topisomerase-1 inhibitors. After completion of his residency in 1996, he worked at the University of Illinois-Peoria and continued to perform radiosurgery. He moved to the Philadelphia area in 1998 and has been working in the Crozer-Keystone Health System since that time. Dr. Lamond’s other research interests include internal radiation (brachytherapy) techniques, particularly high-dose rate brachytherapy for lung and female malignancies. He does clinical research through the Radiation Therapy Oncology Group (RTOG) and is a Clinical Assistant Professor at Temple University School of Medicine. He has treated patients at Philadelphia CyberKnife since July 2006. His radiosurgery special interests include CNS malignancies and the curative treatment of lung cancers.